Lumiliximab [USAN](357613-86-6)
- Name: Lumiliximab [USAN]
- Synonyms:
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:357613-86-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.357613-86-6 Lumiliximab;357613-86-6
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.357613-86-6 Lumiliximab
Assay:95% Appearance:Colorless to light yellow liquid Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 98-95-3/Nitrobenzene
- 5191-80-0/H-CYS(DPM)-OH
- 22083-71-2/N-[3,3-Bis(p-aminophenyl)propyl]benzylamine
- 1516-34-3/1-pentylthiourea
- 19716-78-0/N-(1-Oxodecyl)-Gly-L-Trp-L-Ala-L-Ala-OMe
- 186453-65-6/Hydrazinecarbothioamide, 2-((4-(diethylamino)phenyl)methylene)-N-((4-n itrophenyl)methyl)-
- 25134-83-2/2-Propenoic acid,2-methyl-,esters,methyl ester,polymer with chloroethene
- 66016-27-1/3-tert-Butylcyclobutanecarboxylic acid
- 46687-78-9/ethyl 5,6-O-(oxomethylidene)hexofuranoside
- 57682-64-1/(13R,16aR)-13-[(1R,2S)-1,2-dihydroxyheptyl]-1,4,5,6,7,8,9,10,11,13,16,16a-dodecahydropyrido[2,1-d][1,5,9]triazacyclotridecin-2(3H)-one
- 52889-82-4/4,4'-Di(methyl-d)-1,1'-biphenyl
- 56069-79-5/4-(4-chlorophenyl)-2,2,3,3-tetramethoxycyclobutane-1,1-dicarbonitrile
- 2941-89-1/(2,7-dimethyl-9H-fluoren-9-yl)methanol
- 494-23-5/(2S,5R)-5-(3-Furyl)-2-(2-oxo-4-methylpentyl)-2-methyltetrahydrofuran
- 26364-38-5/2,4(1H,3H)-Pyrimidinedione,1-(3-deoxyhexofuranosyl)-5-methyl- (9CI)
- 89838-96-0/Octimibate
- 73018-91-4/7-Benzothiazolesulfonic acid, 2,2'-[(2-sulfo-1,4-phenylene) bis[imino(1-acetyl-2-oxo-2,1-ethanediyl)azo-4 ,1-phenylene]]bis[6-methyl-, compd. with α,α',α''- (nitrilotri-2,1-ethanediyl)tris[ω-hydroxypoly (oxy-1,2-ethanediyl)] (1:3)
- 142534-72-3/[1,1'-Biphenyl]-2-diazonium,3',4,4',5-tetrachloro-, chloride (1:1)
- 357613-86-6/Lumiliximab [USAN]
- 90563-49-8/6-amino-2-pyrrolidin-1-yl-7,9-dihydro-8H-purine-8-thione
- 63908-37-2/3-(2-methylpropyl)-3,7-dihydro-1H-purine-2,6-dione
- 107316-26-7/2-chloro-1-(2,4-dichlorophenyl)-3-(1H-imidazol-1-yl)-2-phenylpropan-1-one
- 120154-96-3/eilatine
- 94160-04-0/3-amino-4-chloro-N-phenylbenzenesulphonamide
- 2732-58-3/6-ETHYLCHRYSENE
- 198336-56-0/5H-Pyrano[3,2-c]quinolin-5-one,2,6-dihydro- 2-(4-hydroxy-4-methyl-2-pentenyl)-2,6- dimethyl-,(+)-
- 94023-09-3/octaammonium tetrahydrogen [ethane-1,2-diylbis[[(phosphonatomethyl)imino]ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
- 30120-87-7/2-(naphthalen-1-yl)-4-(piperidin-1-yl)-2-[2-(piperidin-1-yl)ethyl]butanal
- 59322-44-0/2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid
- 52-02-8/Furanestrenone